We take the privilege of hosting International Annual Next-Gen Regenerative Medicine & Tissue Engineering Conference worldwide and very excited to expand to Japan. With the valuable support of Scientific Committee Members, Annual Next-Gen Regenerative Medicine & Tissue Engineering Conference planned to be held in the beautiful Osaka, Japan during September 20-21, 2018.

Working under the theme “Novel Perspectives on tissue engineering” we bring together a unique international mix of large and medium medical and clinical research and diagnostic companies, leading universities and medical research institutions. This is a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging innovations around the world. This conference mainly focuses on spreading the emerging techniques related to tissue engineering and regenerative medicine. It’s an exciting time for Tissue Engineering and Regenerative Medicine as we continue in evaluating the novel techniques and innovate a new modality in it.

Meetings International through its Open Access Initiative is committed to create reliable contributions to the scientific field. It organizes 150+ Conferences once a year throughout USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 150+ Open access journals that contains over 10000 eminent personalities, putative scientists as editorial board members.

Annual Next-Gen Regenerative Medicine & Tissue Engineering Highlights:

Tissue Biomarkers
Biochips and Tissue Chips
Scaffolds
Biomaterials and Bioengineering
3D bio printing
Novel Approaches in Guided Tissue Regeneration
Biomedicine
Bone and Cartilage Tissue Engineering
Skin Tissue Engineering
Cardiac Tissue Engineering
Bio artificial Organs
Stem Cell Engineering (SCE)
Cancer Stem Cells
MicroRNA in Regenerative Medicine
Applications of Tissue Engineering and Regenerative Medicine
Regenerative Medicine

We invite all Doctors, Scientists, Research Scholar, Heads, Deans and Professors of tissue engineering departments, Nutraceutical industry, and Healthcare companies, Entrepreneurs, R&D Institutes, Healthcare Innovators, Public Health Professionals, Clinical Researchers, Life Science Investors, Druggists, Diabetes Societies and Associations, Academic Researchers.

Annual Next-Gen Regenerative Medicine & Tissue Engineering will influence an attractive moment to meet people in the experimentation field and therefore it takes a pleasure in opening a doorway to encounter the ability in the field, young researchers and potential World-renowned speakers, the most recent approaches, tactics, and the current upgrade in the field of tissue engineering.

Meetings International of Annual Next-Gen Regenerative Medicine & Tissue Engineering will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other evidence based practice from some of our workshops and symposiums. We hope you will join us in Osaka in September.

Sessions-1: Tissue Biomarkers

Fundamental to the safety of many tissue-engineered medical products is how cells respond to a given polymer when it is implanted into the body. Assurance of cellular stability during the manufacturing, storage and shipment of such products is important to get optimal efficacy. It is therefore important to have cellular biomarkers which measure genetic damage that cells might undergo during tissue engineering.

Session-2: Biochips and Tissue Chips

Biochips refer to the complete fundamental functional unit which is capable of performing multi biochemical tasks simultaneously. On the other hand Tissue chips are similar miniaturized units which can replace a tissue or some part of it, enabling the organ to work normally. Both biochips & tissue chips are basic in tissue engineering technology. DNA microarray also called as biochip in simple terms having two dimensional grid systems where upon sensors or solid flat substrates are incorporated.

Session-3: Scaffolds

Scaffold biomaterials act as templates for tissue regeneration, to monitor the growth of new tissue. These scaffolds are used to maintenance organs and organ systems that may have been damaged after injury or disease. Scaffolds are of excessive importance in clinical medicine. It is a forthcoming field, and typically related with conditions involving organ disease or failure. Hence it is used to reconstruct organs and coming back normal function.

Session-4: Biomaterials and Bioengineering

Biomaterials are widely used for the healthcare applications from the ancient times. But progressive evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel approach to combat life threatening diseases. Together with biomaterials, stem cell technology is also mostly used to improve the existing healthcare facilities. Visible progress was made in the area of biomaterials since 1940s and simultaneous development has been observed in therapeutic medical technologies and implant devices over the past 25 years.

Session-5: 3D-Bioprinting

Three-dimensional (3D) printing is also known as additive manufacturing. It shows main inventions in many areas, like engineering, manufacturing, art, education and medicine. 3D bioprinting is extensively applied in regenerative medicine to fulfill the need for tissues and organs appropriate for transplantation. Applications of this 3D-bioprinted tissue models is for research, drug discovery and toxicology. The capability to 3D print with adult stem cells displays the possible to effect regenerative medicine universally.

Session-6: Novel Approaches in Guided Tissue Regeneration

Tissue engineering represents one of the most exciting advances in regenerative medicine. Guide Tissue Regeneration (GTR) is defined as the procedures of attempting to regenerate lost periodontal structures through differential tissue responses. It lays emphasize on the development of both hard tissue as well as soft tissues of the periodontal supplement. With the help of GTR, 3-dimensional tissues that accurately integrate with a patient's body are been produced.

Session-7:Biomedicine

Biomedicine is the application of the principles of the natural sciences, specifically biology and physiology, to clinical medicine. It is mainly applies to biology and physiology. Biomedicine has been an active model and played an immensely important part in people’s understandings of health and illness. Usually biomedicine finds a problem in a patient and repairs the problem with the help of medical intervention. Objective of Medicine is to curing diseases rather than improving one's health.

Session-8: Bone and Cartilage Tissue Engineering

Bone and cartilage both are the most important components in the skeleton system, providing the major structure of the body of vertebrates and conferring protection of soft tissues. Tissue engineering of musculoskeletal tissues, especially bone and cartilage, is a rapidly developing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Currently tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the genetics and regulation of bone formation have developed new materials for tissue-engineering applications. This information base also has benefited for cartilage tissue engineering.

Session-9: Skin Tissue Engineering

The skin is the largest organ of the body and is act as a barrier to the environment and for thermal regulation and hydration retention. The top layer of the skin, the epidermis which comprised mainly of keratinocytes, provides the barrier against exogenous substances, chemicals, pathogens and prevents dehydration through the regulation of fluid loss. Another cell within the epidermis is melanocytes which give pigmentation and Langerhans’ cells which provide immune surveillance. Extreme loss of skin may occur due to injury and illness which result in ample physiological imbalance and may lead to major disability or even death. Tissue-engineered skin (TES) alternates signify a logical beneficial option for the treatment of severe and chronic skin injuries.

Session-10: Cardiac Tissue Engineering

The most common reason of heart failure is acute or chronic damage to the heart. The human heart has very minute regenerative ability. After a cardiac incident, the loss of heart function cannot be naturally recovered, which harms the quality of life of patients. Currently high improvement seen in the engineering of 3-dimensional (3D) heart muscles. Progresses in human stem cell biology and technology, predict the cardiac tissue engineering methods widespread. Tissue engineering aims at providing living, force-producing heart muscle tissue which can be transplanted on injured or abnormal hearts and can repair normal function.

Session-11: Bioartificial Organs

A bioartificial organ is an engineered device or tissue which is incorporated into human body to replace a natural organ .It combines biomaterials and biological cells for fully replacement of patient failure organs. Examples of bioartificial organ are bioartificial kidney devices, combining biomaterials and kidney epithelial cells for improved blood detoxification, bioartificial pancreas devices, combining encapsulation of pancreatic cells for treatment of diabetes, bioartificial lungs for studying lung regeneration.

Session-12: Stem Cell Engineering (SCE)

The remarkable improvement in the field of stem cell research has set the foundation for cell based treatments of disease which cannot be cured by conventional medicines. The capability of self-renewal and segregate into other forms of cells signify stem cells as borderlines of regenerative medicine. The capability of differentiation of stem cells varies according to the source and according to those regenerative applications also varies. Progresses in gene editing and tissue engineering machinery have permitted the ex vivo remodeling of stem cells grown into 3D organoids and tissue structures for personalized uses.

Session-13: Cancer Stem Cells

Cancer stem cells are like all stem cells which are unspecialised that means they have no tissue-specific structures. They can divide and renovate themselves for long periods and they are capable of give rise to specialised cells. They can therefore summarize tumour heterogeneity as they can be found in tumours. Research so far has proposed they also have multi drug and radiotherapy resistance. Hence there may be more similarities between cancer stem cells and normal stem cells, further research in needed to identify and characterise these cells.

Session-14: MicroRNA in Regenerative Medicine

MicroRNAs (miRNAs) are the noncoding small RNAs which negatively regulate the expression of downstream target mRNAs. These are considered as unique class of molecular targets and therapeutics that may play a vital role in tissue engineering. MiRNAs also act as principal controllers of normal and pathological tissue development. MicroRNAs influence in numerous processes such as damage, repair, and regeneration of tissues. Because of all this reason they are studied as targets and tools for tissue engineering and regenerative medicine.

Session-15: Applications of Tissue Engineering and Regenerative Medicine

Patients who are suffering from disease and injured organs may be treated with transplanted organs. However the severe scarcity of donor organs may create disturbance in organ transplantation. Scientists in the field of regenerative medicine and tissue engineering apply the principles of cell transplantation, material science, and bioengineering so as to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Therapeutic cloning, offers a limitless source of cells for tissue engineering applications. The stem cell field is also advancing rapidly, creating new options for therapy. The aim of this conference is to explore recent advances that have occurred in regenerative medicine and describes applications of these new technologies.

Session-16: Regenerative medicine

Regenerative medicine deals with the technique of replacing, engineering human cells, tissues or organs to reestablish its regular function. It brings together experts in biology, chemistry, computer science, engineering, genetics, medicine, robotics, and other fields to solving the most challenging medical problems. It aims to reestablish both structure and function of damaged tissues as well as organs. It is also repair the organs which become permanently damaged. This method aims to invent techniques to cure earlier untreatable injuries and diseases.

Market analysis

Tissue Engineering Conference is glad to invite you to the upcoming International conference on Annual Next-Gen Regenerative Medicine & Tissue Engineering Conference planned to be held at Osaka, Japan during September 20-21, 2018. The conference emphasizes the theme “Novel Perspectives on Tissue Engineering”. Focusing on the latest ideas and advances for tissue engineering Conference welcomes the innovative strategies in the area of tissue engineering and regenerative medicine research and also proposes a unique opportunity for the explorers from all over the world to gather, share and perceive new scientific interactions upon the various perceptions of Tissue Engineering.

Meetings International organizes 150+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 150+ Open access journals which contain over 10000 eminent personalities, reputed scientists as editorial board members.

Annual Next-Gen Regenerative Medicine & Tissue Engineering Highlights:

Tissue Biomarkers
Biochips and Tissue Chips
Scaffolds
Biomaterials and Bioengineering
3D bio printing
Novel Approaches in Guided Tissue Regeneration
Biomedicine
Bone and Cartilage Tissue Engineering
Skin Tissue Engineering
Cardiac Tissue Engineering
Bio artificial Organs
Stem Cell Engineering (SCE)
Cancer Stem Cells
MicroRNA in Regenerative Medicine
Applications of Tissue Engineering and Regenerative Medicine
Regenerative Medicine

Importance and scope of Tissue Engineering

Tissue engineering is a scientific field which alarmed with the progress of biological substitutes capable of substituting diseased or damaged tissue in human body. The word tissue engineering was introduced in the late 1980s. At the early stage of 1990s the consciousness of engineering application for the reparation of biological tissue bring speedy growth in tissue engineering field with the latent to revolutionize significant areas of medicine.

Tissue engineering integrates biological components, like cells and growth factors, using engineering principles as well as synthetic materials. Substitute tissues can be created by first seeding human cells on scaffolds, which may be prepared from collagen or from a recyclable polymer. The scaffolds are then permitting to incubate in mediums with growth factors, which encourage the cells to grow and division. As cells spread across the scaffold, the substitute tissue is formed. This tissue can be implanted into the human body, with the implanted scaffold ultimately being either absorbed or dissolved.

The highly growing price of organ replacement and more medical uses of 3D printing in tissue and organ regeneration are driving the international tissue engineering and regeneration market. Besides it, this technology is gaining acceptance due to its effectual products and reduced rejection rates. A modern advance in the field of regeneration surgical treatment, primarily stem cell research, is probable to offer novel opportunities for global tissue engineering and regeneration market. Some of the main companies dealing in Tissue engineering and regeneration market are Advanced Cell Technology, Integra Life Sciences, CryoLife, Biomimetic Therapeutics, Sanofi, StemCellsInc, Cook Biotech, Life Cell Kinetic Concepts, Arteriocyte and Bio Tissue Technologies.

The past four years, Tissue Engineering market size to maintain the average annual growth rate of 19.17% from 6500.00 million $ in 2013 to 11000.00 million $ in 2016, Market analysts believe that the next few years, Tissue Engineering market size will be further expanded, we expect that by 2021 , The market size of the Tissue Engineering will reach 24000 million $.

Growth Projections for the Regenerative Medicine Market

Name: Tissue Engineering 2018
Start: 2018-09-20
End: 2018-09-21
Location: Osaka

Why Osaka?

Osaka is a large harbor urban and profitable epicenter for Japan. It's well known for its modern construction, nightlife and hearty street food. The 16th-century shogun ate Osaka Castle, which has undergone numerous restorations, is main historical landmark. It is the second largest metropolitan area in Japan and among the largest in the world having over 19 million populations. Situated at the doorway of the Yodo River on Osaka Bay, providing as a chief economic hub for the nation. It is the home of Universal studios Japan, Osaka castle, Dotonbori, Osaka Aquarium Kaiyukan.

Target Audience:

We are privileged to welcome the: Directors of Tissue Engineering, Heads and Professors of Tissue Engineering and Regenerative Medicine departments, Scientists and Researchers organizers, Doctors, Medical Colleges, Healthcare professionals, Founders and Employees of the related companies, , Hospitals and Health Services, Clinical investigators Pharmaceutical companies, Laboratory members, Training institutions, Support organizers, Data Management Companies, Cardiologists training and education.

Major Societies for Tissue Engineering

Japan

Korean Tissue Engineering and Regenerative Medicine Society
TERMIS-EU (formerly European Tissue Engineering Society)
The Tissue and Cell Engineering Society (TCES), UK
Tissue Engineering and Regenerative Medicine International Society

Globe

American Institute for Medical and Biological Engineering
American Society of Biomechanics
American Society for Engineering Education, Biomedical Engineering Division (ASEE BME)
American Society of Mechanical Engineers, Bioengineering Division
Association for the Advancement of Medical Instrumentation
Biomedical Engineering Society (BMES)
European Society for Biomaterials (ESB)
European Society of Biomechanics (ESB)
IEEE Engineering in Medicine and Biology Society (EMBS)
Institute of Biological Engineering (IBE)
Institute of Physics and Engineering in Medicine (IPEM)
International Federation for Medical and Biological Engineering
International Society of Biomechanics
International Society for Prosthetics and Orthotics (ISPO)
International Union for Physical and Engineering Sciences in Medicine (IUPESM)
Public Library of Science (PLoS)
Society for Biomaterials

Hospitals Associated with Tissue Engineering:

Japan:

The University of Tokyo Hospital
Hiroshima University Hospital
Center for Experimental Medicine and Systems Biology
Advanced Clinical Research Center
Center for Stem Cell Biology and Regenerative Medicine Health Intelligence Center
Center for Gene and Cell Therapy

Highlights
Supporting Journals

Tissue Biomarkers
Biochips and Tissue Chips
Scaffolds
Biomaterials and Bioengineering
3D-Bioprinting
Novel Approaches in Guided Tissue Regeneration
Biomedicine
Bone and Cartilage Tissue Engineering
Skin Tissue Engineering
Cardiac Tissue Engineering
Bioartificial Organs
Stem Cell Engineering (SCE)
Cancer Stem Cells
MicroRNA in Regenerative Medicine
Applications of Tissue Engineering and Regenerative Medicine
Regenerative medicine

Facebook

Annual Next-Gen Regenerative Medicine & Tissue Engineering Conference

Tissue Engineering 2018

Submit Abstract

Register Now

Scientific Program

Theme: Novel Perspectives on Tissue Engineering

Growth Projections for the Regenerative Medicine Market